Inhibitors Make Rare Landing On Longstanding Anticancer Target Ras

Drug Discovery: Despite decades of effort, no Ras inhibitors have passed clinical trials, but cyclic peptides provide new options

via Chemical & Engineering News: Biological SCENE http://ift.tt/1FYSgVe